These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 11463531

  • 1. Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants.
    Fung-Tomc J, Gradelski E, Huczko E, Minassian B, Bonner DP.
    Int J Antimicrob Agents; 2001 Jul; 18(1):77-80. PubMed ID: 11463531
    [Abstract] [Full Text] [Related]

  • 2. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
    Hoellman DB, Lin G, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of bacterial isolates to gatifloxacin and ciprofloxacin from clinical trials 1997-1998.
    Huczko E, Conetta B, Bonner D, Valera L, Stickle T, Macko A, Fung-Tomc J.
    Int J Antimicrob Agents; 2000 Dec; 16(4):401-5. PubMed ID: 11118848
    [Abstract] [Full Text] [Related]

  • 4. Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
    Kosowska-Shick K, Credito K, Pankuch GA, Lin G, Bozdogan B, McGhee P, Dewasse B, Choi DR, Ryu JM, Appelbaum PC.
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2064-71. PubMed ID: 16723567
    [Abstract] [Full Text] [Related]

  • 5. [Comparative in vitro activity of garenoxacin (BMS-284756). Sentry program, Spain (1999-2000)].
    Loza E, Cantón R, Pascual A, Tubau F, Morosini MI, Almaraz F, Perea E, Martín R, Jones RN, Baquero F.
    Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):404-9. PubMed ID: 14525705
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms and frequency of resistance to gatifloxacin in comparison to AM-1121 and ciprofloxacin in Staphylococcus aureus.
    Ince D, Hooper DC.
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2755-64. PubMed ID: 11557465
    [Abstract] [Full Text] [Related]

  • 7. grlA and gyrA mutations and antimicrobial susceptibility in clinical isolates of ciprofloxacin- methicillin-resistant Staphylococcus aureus.
    Coskun-Ari FF, Bosgelmez-Tinaz G.
    Eur J Med Res; 2008 Aug 18; 13(8):366-70. PubMed ID: 18952518
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of fluoroquinolones against ocular bacterial isolates in São Paulo, Brazil.
    Oliveira AD, D'Azevedo PA, Francisco W.
    Cornea; 2007 Feb 18; 26(2):194-8. PubMed ID: 17251812
    [Abstract] [Full Text] [Related]

  • 9. Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents.
    Gradelski E, Kolek B, Bonner DP, Valera L, Minassian B, Fung-Tomc J.
    Int J Antimicrob Agents; 2001 Feb 18; 17(2):103-7. PubMed ID: 11165113
    [Abstract] [Full Text] [Related]

  • 10. Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.
    Drugeon HB, Juvin ME, Bryskier A.
    J Antimicrob Chemother; 1999 Jun 18; 43 Suppl C():55-9. PubMed ID: 10404339
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
    Naber KG, Hollauer K, Kirchbauer D, Witte W.
    Int J Antimicrob Agents; 2000 Nov 18; 16(3):239-43. PubMed ID: 11091042
    [Abstract] [Full Text] [Related]

  • 12. Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae.
    Nagai K, Davies TA, Dewasse BE, Jacobs MR, Appelbaum PC.
    J Antimicrob Chemother; 2001 Sep 18; 48(3):365-74. PubMed ID: 11533001
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM, Mazzucco CE, Lawrence LE, Ho H, Warr G, Barrett JF, Frosco M.
    Eur J Clin Microbiol Infect Dis; 2002 Jan 18; 21(1):27-34. PubMed ID: 11913498
    [Abstract] [Full Text] [Related]

  • 14. Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacin.
    Pong A, Thomson KS, Moland ES, Chartrand SA, Sanders CC.
    J Antimicrob Chemother; 1999 Nov 18; 44(5):621-7. PubMed ID: 10552978
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA, Jacobs MR, Appelbaum PC.
    Diagn Microbiol Infect Dis; 1997 Jul 18; 28(3):131-7. PubMed ID: 9294703
    [Abstract] [Full Text] [Related]

  • 16. Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.
    Browne FA, Bozdogan B, Clark C, Kelly LM, Ednie L, Kosowska K, Dewasse B, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 2003 Dec 18; 47(12):3815-24. PubMed ID: 14638489
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone.
    Otani T, Tanaka M, Ito E, Kurosaka Y, Murakami Y, Onodera K, Akasaka T, Sato K.
    Antimicrob Agents Chemother; 2003 Dec 18; 47(12):3750-9. PubMed ID: 14638477
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
    Zhanel GG, Roberts D, Waltky A, Laing N, Nichol K, Smith H, Noreddin A, Bellyou T, Hoban DJ.
    J Antimicrob Chemother; 2002 May 18; 49(5):807-12. PubMed ID: 12003975
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
    Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K.
    Antimicrob Agents Chemother; 1992 Oct 18; 36(10):2108-17. PubMed ID: 1332587
    [Abstract] [Full Text] [Related]

  • 20. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
    Fung-Tomc J, Minassian B, Kolek B, Washo T, Huczko E, Bonner D.
    J Antimicrob Chemother; 2000 Apr 18; 45(4):437-46. PubMed ID: 10747819
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.